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KESAN PENDEDAHAN PARAQUAT TIGA BULAN TERHADAP USUS 




Paraquat (PQ) adalah racun herba yang digunakan di seluruh dunia kerana 
keberkesanannya yang tinggi dan aktiviti herbisida yang cepat bertindak. Walaupun 
demikian, penggunaan paraquat juga menyebabkan beberapa kesan negatif terhadap 
kesihatan manusia dan keselamatan alam sekitar. Banyak penyakit kronik seperti 
penyakit Parkinson, dermatitis, gangguan fungsi paru-paru, dan kanser telah dikaitkan 
dengan pendedahan paraquat dalam kajian epidemiologi. Walaupun begitu, kesan 
negatif ini belum dapat dibuktikan kerana kekurangan model haiwan yang sesuai 
dalam melakukan kajian kronik yang dapat mensimulasikan penyerapan PQ yang 
perlahan dalam keadaan harian. Oleh itu, kajian awal ini bertujuan untuk menganalisis 
kemungkinan penyerapan PQ pada organ utama selepas pengambilan makanan yang 
telah dirawat dengan PQ selama 3 bulan. Empat kumpulan tikus diberi diet normal dan 
makanan yang dirawat PQ pada dos yang berbeza iaitu 30 mg/Kg, 60 mg/Kg dan 100 
mg/Kg, masing-masing. Setelah menjalani rawatan makanan selama tiga bulan, organ-
organ utama tikus (peparu, hati, buah pinggang, dan usus) yang berkaitan dengan 
toksisiti paraquat dikumpul dan dianalisis memalui histopatologi konvensional dan 
perwarnaan imuno. Dari analisis histologi H&E, perbezaan yang tidak ketara antara 
organ-organ utama kumpulan kawalan dan yang menerima makanan yang 
mengandungi PQ. Walaupun begitu, dari analisis pewarnaan imunohistokimia, 
mungkin terdapat peningkatan yang signifikan dalam pemendapan paraquat pada 
organ-organ utama, terutama tisu usus di mana ia merupakan lapisan terdepan terhadap 
xi 
 
makanan yang mengandungi PQ. Peningkatan dos PQ mungkin akan juga meningkat 
isyarat pewarnaan imunohistokimia. Kesimpulannya, PQ dapat diserap dan dikesan 
dalam tisu hidup setelah pengambilan makanan yang telah dirawat PQ. Kesan PQ pada 
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Paraquat is an herbicide that was use worldwide due to the high cost-
effectiveness and fast acting herbicidal activities. Nonetheless, the use of paraquat has 
also led to several health and environmental adverse consequences. Many chronic 
diseases such as Parkinson’s disease, dermatitis, impaired lung function, and cancer 
have been associated with paraquat exposure in epidemiological studies. Nonetheless, 
the causal effect is yet to be proven due to the lack of a appropriate animal model in 
performing the chronic studies which could simulate the slow PQ absorption under 
normal daily condition. Hence, this preliminary study aimed at analyzing the possible 
absorption of paraquat (PQ) in major organs flowing a 3-month PQ-treated diet. Four 
groups of rats were treated with normal diet and PQ-treated diet at different doses i.e. 
30 mg/Kg, 60 mg/Kg and 100 mg/Kg, respectively. Upon the three months diet 
treatment, the major organs of the rats related to paraquat toxicity were harvested and 
subjected to conventional and immune-histopathological analysis. From the H&E 
histological analysis, non-significant differences among the among the major organs 
between the control and PQ-diet groups were anticipated. Nonetheless, from the 
immunohistochemical staining analysis, there might be a significant increase in the 
paraquat deposition or infiltration in the major organs, particularly the intestinal tissues 
wherein it is the frontline layers exposure to the PQ-diet. There might be a dose-
dependen relationship between PQ doses and the immunohistochemical staining signal. 
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In conclusion, the PQ-treat diet could be absorbed and detected in the living tissues 
following a PQ-treated diet. Effect of the toxic substances to the surrounding tissues 






CHAPTER 1 1 
  2 
INTRODUCTION 3 
 4 
1.1 Paraquat 5 
Paraquat (1,1'-Dimethyl-4,4'-bipyridinium dichloride) is a nonselective contact 6 
herbicide commonly used to control broad leaf and grassy weed. It is one of the most 7 
used herbicides globally. Paraquat was first synthesized in 1882 as a redox indicator. 8 
Its herbicidal property was only recognized later in the 1950’s and was introduced to 9 
the market as herbicides in early 1960’s (Sittipunt, 2005). Paraquat is produced in 10 
several countries, including China, Province of Taiwan, Italy, the United Kingdom, 11 
and the USA and are used in more than 130 countries world-wide. Paraquat is labor 12 
saving and cheap, and therefore especially popular and accessible to farmers in 13 
developing countries (Wesseling et al., 2001). The chemical structure is as shown in 14 
Figure 1.1. 15 
   16 
 17 
Figure 1.1 Molecular structure of PQ 18 
 19 
They are also used at home and at work to ensure a pest-free environment. As 20 
a result of these, many problems such as unsafe use, persistence in environment, 21 
toxicity to bees, fish and wild life, contamination of water sources, persistent pesticide 22 
accumulating in food chain, negative impact on earthworms and other beneficial 23 
organisms has been identified. In developing countries, pesticides are routinely used 24 
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in unsafe conditions and farmers lack training and resources to increase safety to their 25 
own health and environment (Akinloye et al., 2011). 26 
 27 
The minimum lethal dose of paraquat is stated to be about 35 mg/kg body 28 
weight for human (Tang et al., 2017b). The Symptoms of poisoning depend on the 29 
dose absorbed.  It is difficult to estimate the dose absorbed from case histories since in 30 
many cases the patients spat out part of the paraquat concentrate or vomited profusely 31 
after swallowing the herbicide. Some patients have survived after apparently ingesting 32 
50 - 100 mL  Gramoxone(R) (10 - 20 g paraquat), whereas some died after taking as 33 
little as 2 sachets of Weedol (2.5 g paraquat) (WHO, 1984). Furthermore, absorption 34 
of an ingested dose of paraquat may be reduced by gastric lavage, induced emesis, 35 




Figure 1.2 Paraquat and its function in agriculture 40 
 41 
According to(Choi, 2013 #149), Globally, there are about 20,000 annual 42 
fatalities and more than 2 million hospitalizations due to poisoning by pesticides and 43 
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agricultural chemical (Sittipunt, 2005). The fatality rate of PQ intoxication remains 44 
high due to the lack of an effective treatment. Current treatments include adsorbents, 45 
pharmacological approaches, radiotherapy, extracorporeal therapy, and 46 
immunosuppressive therapy, but the effectiveness of these therapies remains 47 
controversial. It is generally known that, the very high case fatality of paraquat is due 48 
both to its inherent toxicity and the lack of any effective treatment (Gawarammana and 49 
Buckley, 2011).  50 
 51 
The restricted paraquat could add to the social distress associated with high 52 
suicide rates among subsistance farmers, by banning an essential tool to feed their 53 
families and enhance their prosperities. Paraquat has been banned or restricted in a 54 
number of countries. The US Environmental Protection Agency (EPA) allows its 55 
purchase and use solely by certified applicators. Paraquat is prohibited in Sweden, 56 
Finland, and Austria based on acute toxicity and absence of antidote. In Norway, the 57 
manufacturers canceled voluntarily its registration. In Germany and in The 58 
Netherlands, paraquat was banned because of its persistence in soil. The ban was 59 
subsequently lifted. Paraquat is being reviewed in the European Union and is in use in 60 
10 of the 15 EU member states (http://europa.eu.int, status of current authorizations in 61 
December 2000) (Wesseling et al., 2001). In Malaysia, the use of paraquat was banned 62 
in 2005 but was reintroduced into the market a year later and is currently available as 63 
a result of frequent and serious poisoning involving this agent. The number of calls 64 
relating to paraquat exposure when it was banned was 67 (36 and 31 in 2005 and 2006 65 
respectively). After its re-introduction, there was a marked increase in the number of 66 




1.2 Paraquat Toxicity 69 
Despite agriculture benefits, paraquat is extremely toxic to both humans and animals. 70 
Death cases due to intentional and accidental poisonings are frequently reported 71 
worldwide. Most incidents are caused by ingestion of the concentrated solution 72 
intended for agricultural use. Local effects include damage to the skin, nails, mouth, 73 
eyes and nose. Sore throat, dysphagia and epigastric pain may occur. Systemic effects, 74 
which produce the fatal outcome seen in those who have ingested a sufficient quantity 75 
of paraquat, mainly involve the respiratory system. The changes in the lungs that 76 
underly the symptoms and clinical signs comprise a proliferative alveolitis similar to 77 
that seen in most experimental animals treated with paraquat. In most, but not all, 78 
patients who develop the characteristic lung changes, the condition progresses 79 
inevitably towards a fatal outcome, death being due to respiratory failure. If 80 
overwhelming dose is taken, death is usually due to multi-organ failures. Numerous 81 
therapies have been tested, but none has been consistently successful (Marrs, 2003). 82 
The high mortality rate observed following paraquat exposure has been attributed to 83 
the lack of an antidote or effective treatment to ameliorate the toxic effect of poison 84 
(Gawarammana and Buckley, 2011). PQ induces its toxic effect mainly via oxidative 85 
stress–induced mechanisms (Suntres, 2002; Suntres, 2018).  86 
 87 
1.3 Toxicokinetics of paraquat 88 
Meredith and Vale (1987) demonstrated that, in human, PQ is absorbed incompletely 89 
from the gut and, it has been estimated that less than 5% of an ingested dose is absorbed 90 
over a 1-6-h period. Upon absorption, PQ is rapidly distributed via bloodstream to the 91 
whole-body systems. Under normal circumstances, the storage is not prolonged in any 92 
of the organ tissues, as it is being excreted by the kidney. Absorbed PQ mainly 93 
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eliminated as parent compound within 24 hours if the function of kidney is normal. In 94 
case of high dose ingestion, disturbance of normal kidney function is disturbed and 95 
may cause acute tubular necrosis which eventually affect the elimination process as 96 
well as prolonged the deposition of PQ in the tissues. Consequently, it can lead to 97 
multiorgan injuries and death which usually occur within hours and days. At moderate 98 
doses, delayed death due to lung fibrosis and respiratory failure usually occurs within 99 
weeks and month. Due to the structural similarity with naturally occurring polyamine, 100 
PQ is selectively absorbed and accumulated in the lungs, and exerts it major toxic 101 
effect in the lungs. 102 
 103 
1.4 Mechanism of Toxicity 104 
The cellular toxicity of paraquat is primary due to its redox cycle (Figure 1.4). It 105 
includes a well-known cascade of molecular reactions leading to NADPH 106 
consumption and to generation of reactive oxygen species (ROS) i.e. primarily 107 
hydrogen peroxide (H2O2) and hydroxyl radical (OH). These ROS causes deleterious 108 
effect on affected tissues (Akinloye et al., 2011). PQ is metabolized by several enzyme 109 
systems (NADPH-cytochrome P450 reductase, xanthine oxidase, NADH-ubiquinone 110 
oxidoreductase and nitric oxide synthase). Its metabolism through these systems 111 
generates a paraquat mono-cation radical (PQ+). Inside the cell, PQ+ rapidly gets re-112 
oxidized to PQ2+ and in the process it generates superoxide (O2
-). O2 acts as an electron 113 
acceptor and NADP as an electron donor in this reaction. Generation of highly reactive 114 
oxygen and nitrite species results in toxicity in most organs but the toxicity is 115 
particularly severe in the lungs as paraquat is taken up against a concentration gradient 116 





Figure 1.3 Consequences of paraaquat upon ingestion 120 
Note: 121 
(A) Paraquat tongue’ early lesion, within 24 h after ingestion. (B)Paraquat tongue late lesion, 2 weeks 122 
after ingestion with extensive ulceration (Gawarammana and Buckley, 2011) 123 
 124 




Figure 1.4 Graphical representation of paraquat toxicity inside a pneumocyte and 127 
potential sites of antidotal therapy.  128 
 129 
Note: 130 
SOD, superoxide dismutase; CAT, catalase; Gred, glutathione reductase; Gpx, 131 
glutathione peroxidase; FR, Fenton reaction; HWR, Haber-Weiss reaction.1–8: 132 
potential sites of action by available treatment options.1: activated charcoal and 133 
Fuller’s earth;2: dialysis;3,4,6 and 8: salicylates;5 and 8: N-acetylcysteine;7 (P-134 
glycoprotein induction): dexamethasone; 4: immunosuppression (Gawarammana and 135 
Buckley, 2011).  136 
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1.5 Analysis Assay 137 
Paraquat detected from human blood, urine, and feces, separated on a strong acid 138 
cation exchange resin, reacted with Sodium dithionite, and determined 139 
spectrophotometrically at 391 nm. Paraquat ion can be determined with Na diothionite 140 
in clear urine, 1 pg/mL , and cloudy urine, 1.5 pg/mL . Urine can be passed through a 141 
Dowex AG 50W-X8 resin column either untreated or treated with 18N HzS04 or 25% 142 
trichloroacetic acid. The column was eluted with 2.5% NH4 C1 and the eluate reacted 143 
with Na dithionite to produce the blue free radical, which was determined 144 
spectrophotometrically at 392, 396, 400, and 401 nm. The method was sensitive to 145 
0.01 pg ion per mL in a 250 mL aliquot of urine. Gas-liquid chromatography (GLC) 146 
cannot be used with paraquat because the polar nature of the chemical makes its 147 
extraction and concentration by organic solvents impossible, and results obtained by 148 
this method must be viewed with suspicion (Haley, 1979). 149 
 150 
Generally, chromatographic and spectrophotometric methods for 151 
determination of paraquat in human tissues showed that the earlier method could not 152 
be used because of the presence of large amounts of contaminations. Even though, 153 
Paraquat is not concentrated by liver, kidney, or brain but achieves a lung 154 
concentration 10 times that of rat plasma, so the main target is lung more than other 155 
organs. In vitro, paraquat has no effect on lung surfactant, but in vivo surfactant is 156 
severely reduced or absent (Gawarammana and Buckley, 2011). 157 
 158 
1.6 Chronic Toxicity 159 
Chronic health effects of paraquat toxicity is associated with increased risk of 160 
Parkinsonism, it may relate to genetics, environmental, or both (Peng et al., 161 
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2009)Generally, exposed patients suffer from loss of neurotransmitter cells (dopamine 162 
cells). Moreover, diffusion tensor imaging (DTI) revealed deficiencies in fractional 163 
anisotropy (FA) of substantia nigra (SN) when compared to normal people, which are 164 
similar parameters with non-exposed PD patients. Not to mention that the ROS activity 165 
of PQ can inflect oxidative stress on the cytosol and mitochondrial matrix of 166 
neuroblastoma cells (Rodriguez-Rocha et al., 2013). Also, low dosage poisoning over 167 
a long period of and iron exposure can increase the risk of PD. Chronic respiratory 168 
defects, it can cause gas exchange abnormalities in the lung (Schenker et al., 2004). de 169 
Jong et al. (2014) reported that PQ can gradually reduce lung function in proportionate 170 
with time. Additionally, PQ can impair the immune system by reducing the 171 
proliferative responses of T and B lymphocytes, reducing IgM plaque-forming cell 172 
counts, Inhibition of antigenic responses of B cell, and TH17 cells related autoimmune 173 
diseases (Hassuneh et al., 2012)  Also skin exposure to PQ can cause dermatitis and 174 
severe skin irritation. Reproductive and Endocrine toxicity due to PQ is also reported 175 
by studies. In Malaysia, a significant reduction in semen quality among farmers who 176 
use PQ (Hossain et al., 2010). Among workers who had been in contact with PQ, a 177 
reported increase in birth defects in children. On animals, PQ can affect embryonal 178 
development (Hausburg et al., 2005). Genetic alterations were also been reported due 179 
to PQ. Mothers being exposed to PQ can cause leukemia in their children (Monge et 180 
al., 2007). Other malignancies also have been reported due to PQ, brain cancer (Engel 181 
et al., 2005), non-Hodgkin’s lymphoma (Park et al., 2009), skin melanoma (Dennis et 182 
al., 2010), and breast cancer (Engel et al., 2005).  183 
 184 
1.7 Toxicological Studies on Animal Models 185 
Animal models were commonly used for toxicological studies of potentially harmful 186 
substances to support the potential anticipation of similar effect on humans. The 187 
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toxicological effect of paraquat on animals such as rat is evidence by the survival and 188 
histopathological findings on major organs such as lungs, liver, kidney and intestine 189 
(Choi et al., 2013; Zhi et al., 2011). 190 
 191 
1.7.1 Lung Pathohistological Studies 192 
According to Choi et al. (2013), the major abnormal or pathological findings of PQ 193 
toxicity related to lungs were the of increased alveolar wall thickness, hemorrhage, or 194 
cellular infiltration, while the control were showing thin alveoli epithelial with porous 195 
air sacs (Figure 1.5). Similar studies by Zhi et al. (2011) revealed worsening lung 196 
interstitial edema and widespread inflammatory cell infiltration in the alveolar space 197 
and septum, as well as fibrosis in PQ treated rat, from day-7 tissue to day-28 tissue 198 
(Figure 1.6). 199 





Figure 1.5 Histological comparison of lungs with and without paraquat treatment 203 
Note: 204 
Photomicrographs of lung sections stained with H&E (original magnification × 100) 205 
(Choi et al., 2013). (A) Healthy control with a normal lung structure and no evidence 206 
of increased alveolar wall thickness, hemorrhage, or cellular infiltration; (B) Paraquat 207 
injection (35 mg/kg) only, with numerous inflammatory cells infiltrating the alveolar 208 
septum and spaces together with hemorrhage and congestion. 209 




A.  B.  212 
Figure 1.6 Lung pathalogical findings in rat treated with PQ 213 
Note:  214 
Histological evaluation of rat lungs with paraquat hematoxylin and eosin staining 215 
(H&E×200). PQ intoxicated rat lung on day-7 (A) showed acute injury with interstitial 216 
edema and widespread inflammatory cell infiltration in the alveolar space and septum, 217 
whereas, PQ intoxicated rat lung on day-28 (B) showed widespread inflammation in 218 
alveolar spaces and septum and evident fibrosis was seen (blue arrows represented 219 
deposited collagen). 220 
  221 
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1.7.2 Liver Pathohistological Studies 222 
Histopathological examination of liver section from PQ group rats revealed congestion 223 
in central vein. Granular and vacuolar changes near sub-capsular area with thickening 224 
of glisson’s capsule noticed (Figure 1.7 and Figure 1.8). Section also revealed 225 
prominent reticular cells in the hepatic lobules and proliferation of bile ducts, 226 
suggesting hyperplasia of bile ducts. Sections from PQ group rats revealed granular 227 
and prominent vacuolar changes in the parenchyma of liver and congestion in central 228 
veins Focal areas of necrosis around central vein and periportal hyperplasia of bile 229 
ducts were noticed. In few sections, central lobular area revealed atrophy of 230 
hepatocytes with necrosis. 231 
 232 
1.7.3 Kidney Pathohistological Studies 233 
Sections of kidney from rats1 revealed congestion, focal hemorrhages, desquamation 234 
of tubular epithelium in lumen, decrease in glomerular size and tubular nephrosis 235 
(Figure 1.9). Sections from PQ group rats showed severe congestion, decreased in size 236 
of the glomeruli, hemorrhages, granular and degenerative changes in the tubular 237 
epithelium and desquamation in the lumen. Dilated tubules, cloudy swelling, vacuolar 238 
changes and necrosis of tubular epithelium results in occlusion of the lumen were 239 





Figure 1.7 Section of liver from group-II rat showing granular and vacuolar 243 
changes and reticular cell hyperplasia. H and E stain 200X 244 
 245 
 246 
Figure 1.8 Section of liver from group-II rat showing thickened Glisson’s capsule. 247 





Figure 1.9 Section of kidney from group-II rat showing severe venous congestion. 251 
H and E stain 100X 252 
 253 
Figure 1.10 Section of kidney from group-III rat showing tubular nephrosis and 254 





Figure 1.11 Section of kidney from group-IV rat showing congestion, hemorrhages, 258 
tubular nephrosis and decrease in glomerular size. H and E stain 100X 259 
 260 
1.7.4 Intestine Pathohistological Studies 261 
The animal studies of paraquat intoxification in intestine is limited (Debe et al., 2007; 262 
Lalruatfela et al., 2014). Both studies reported histological changes in the intestine 263 
followings intra-peritonial administration of paraquat solution at different doeses.  264 
According to Lalruatfela et al. (2014), the major pathological findings in the rat tissues 265 
treated with paraquat were distortion and desquamation of epithelium in the lumen of 266 
intestine. Debe et al. (2007) revealed mucosal ulceration, loss of villi, luminal and 267 
stromal edema, and glandular necrosis in the small intestine. The degree of the 268 
abnormality is dose dependent, wherein the degree of distortion increased with the 269 
added treatment dose. As compared to the normal histological findings, the distinct 270 
characteristics of lumen, villi, mucosa, and muscularis mucosae were depreciated 271 
(The-Human-Protein-Atlas, 2020). 272 
 273 
  274 
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A.  275 
B.   276 
Figure 1.12 Intestine pathalogical findings in rat treated with PQ 277 
 278 
Note: 279 
A. Section of H&E stained intestinal tissue in the normal control rat group; B. sections 280 
from intestine of rat showed distortion and desquamation of epithelium in the lumen 281 
of intestine after PQ exposure (H&E stain )100X 282 
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1.8 Treatment of Paraquat Toxicity 283 
The possibility of recovery clearly depends on the dose of paraquat taken and the time 284 
interval between ingestion and the commencement of emergency treatment (WHO, 285 
1984). Treatment should consider both the mechanism of toxicity and toxicokinetics 286 
of paraquat poisoning (Table 1.1). Plasma paraquat concentrations, urine and plasma 287 
dithionite tests and clinical features provide a good guide to prognosis. Activated 288 
charcoal and Fuller’s earth are routinely given to minimize further absorption. 289 
Elimination methods such as haemodialysis and haemoperfusion are unlikely to 290 
change the clinical course. Immunosuppression with dexamethasone, 291 
cyclophosphamide and methylprednisolone is widely practiced, but evidence for 292 
efficacy is very weak. Antioxidants such as acetylcysteine and salicylate might be 293 
beneficial through free radical scavenging, anti-inflammatory and NF-kB inhibitory 294 





Table 1.1 Treatment recommendation following PQ exposure 
 




1.9 Problem Statement 
Residues of PQ in foods are usually detectable especially when it is used as a 
preharvest desiccant or pre-plant applications in food crops such as cereals where its 
levels reached 0.2 mg/kg (Akinloye et al., 2011). Paraquat used for weed control pre-
planting, new crops pick up traces of the chemical from dead plant debris and soil that 
it pushes through, thus leading to residues in the harvested crops. For example, small 
quantities of PQ (< 0.2 ppm) were reported to be detectable in the foliage of certain 
crops such as sugar beet and cereals. Repeated treatment with PQ resulted in soil build-
up and crop damage. Long-term paraquat exposure has been associated with many 
chronic diseases such as Parkinson’s disease, dermatitis, impaired lung function, 
genotoxicity, and kidney damage in human studies. These studies were correlational 
studies, and the evidence are weakened by the presence of appropriate normal control 
to exclude the potential cofounding factors like genetic, lifestyles, and types of 
exposed toxic substances. An appropriate animal models though could not represent a 
human body system; this model can provide insight into the effect of mono-herbicide 
i.e. paraquat on the body organs. Nonetheless, the time required for the development 
of chronic model is long. The longer the established chronic model, the potentially 
higher amount of paraquat residues accumulated in the body organs (PAN, 2017; Shin-
Yuan Chen, 2010). Thus far, there was study focus on the deposition of PQ in an acute 
model following intravenous exposure, but not in a long-term PQ exposure models 
(Masataka et al., 1990). 
 
1.10 Rationale of the Study 
Currently available animal model evidence on paraquat toxicity were based on acute 
toxicity experiments. The evidence of paraquat toxicity based on prolonged paraquat 
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exposure experiment is limited (Minnema et al., 2014). Nonetheless, unveiling the 
effect of prolonged paraquat exposure is important as this would provide insight into 
the impact of prolonged paraquat on the targeted organs, especially the guts and lungs 
(Claus et al., 2016; Tang et al., 2017b). 
 
1.11 Study Objective 
The general objective of the study is to determine the possible effects of three-month 
paraquat exposure on the morphological features of selected rat major organs. 
 
Specific objectives 
i. To compare the tissue morphological change in selected rat organs 
between control and treatment groups. 
ii. To compare the deposition of PQ in selected rat organs between control 






1.12 Overview of the Study 














Male Sprague-Dawley rats 
(n=12; aged 8-week old) 
Ad libitum feeding of thee rats with customised food pellets containing 
different doses of paraquat 
Sacrifice 3 months after paraquat exposure 
Collection of ileum, lung, liver and kidney 
Histopathological assessments 
(i) Haematoxylin & Eosin(H&E) staining 











Male Sprague-Dawley rats (n=12) aged eight weeks’ old were purchased from the 
Animal Research and Service Center, Health Campus, USM, Kubang Kerian, Kelantan, 
Malaysia.  
 
2.1.3 List of Chemicals and Reagents 
Chemicals used in this study are listed in Table 2.1. 
 
2.1.4 List of Kits and Consumables 
Kits and consumables used in this study are listed in Table 2.2. 
 
2.1.5 List of Equipment 




Table 2.1 List of chemicals  
Chemical / Reagent  Manufacturer 
Food pellet Sigma Aldrich, USA 
Bedding Sigma Aldrich, USA 
Paraquat dichloride (3 bottle of 1L) Merck, Germany 
Absoulute alcohol Merck, Germany 
Xylene  Merck, Germany 
Paraffin Sigma Aldrich, USA 
Haematoxylin Merck, Germany 
Eosin  Merck, Germany 
10% buffered formaldehyde Merck, Germany 
Formalin Merck, Germany 
Ethanol 70%,90%,100% Merck, Germany 
Sheep anti-Paraquat antibody (ab53431) Abcam, USA 
HRP-conjugated rabbit anti-sheep antibody Abcam, USA 
DPX Mounting Media Merck, Germany 
Phosphate buffered saline tablets Merck, Germany 
  
